ERT Adds Centralized Data Surveillance for Respiratory Trials

Article

Applied Clinical Trials

Features of the Centralized Data Surveillance include: • Assessing protocol risks, needs and key performance metrics such as site proficiency, calibration, rest between maneuvers, protocol adherence, acceptable/unacceptable Best Test Review data errors impacting the start of tests, and amount of data with repeatability issues

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions announced Centralized Data Surveillance to support Risk-Based Monitoring in respiratory clinical research.

Features of the Centralized Data Surveillance include:

  • Assessing protocol risks, needs and key performance metrics such as site proficiency, calibration, rest between maneuvers, protocol adherence, acceptable/unacceptable Best Test Review data errors impacting the start of tests, and amount of data with repeatability issues

  • Analyzing endpoint data in near real-time to continuously fine-tune the monitoring strategy

  • Supporting or executing an intervention plan to address risks and data deviations as they arise, targeting sites for training, on-site monitor visits and other interventions to boost data quality

Read the full release.

 

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.